May.17 BMRN Long case study

 

BMRN 是生化制药板块的一个股票,下次季报在July.15, 目前正在一个非常狭窄的wedge里面盘整,有望向上突破。具体参考位置如图。再次跌破56块该判断不成立。这个股票所处的大背景是动能股票的领头羊生化板块IBB自从二月底开始的25%巨大调整。生化板块目前正在处于一个重心不断提高的铸底过程,如果上周五HL也成立的话,那就是Apr.15以来的第三个HL。第三个HL是Wedge 中最关键的一个下测。Let's stay with price action. 案例研究,重在学习,不是推荐。

BMRN DAILY CHART

IBB DAILY CHART

Disclaimer: All the trade ideas mentioned here are NOT investment recommendations

BSI* is NOT a Broker Dealer, and BSI* is NOT an investment advisor. The information provided in this place neither is, nor should be construed, as an offer, or a solicitation of an offer, to buy or sell securities. You shall be fully responsible for any investment decisions you make, and such decisions will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs.

BSI refers to Beacon Securities Institute and their teachers including Hong Wang, Hong Xue Tong, Situ Jie

ssl

版权  © 2024 , Beacon Securities Insititute Inc. 保留所有权利